User guide
Safety Information
Medtronic Diabetes Continuous Glucose Monitoring System
Indications for use The CGM System in intended to continuously record interstitial glucose levels in
persons with diabetes melitus. This information is intended to suppliment, not replace, blood glucose
information obtained using standard home glucose-monitoring devices. A conrmatory ngerstick
is required prior to treatment. This information collected by CGM may be downloaded and displayed
on a computer and reviewed by you and your healthcare professional. This information may allow
identication of patterns of glucose-level excursions above or below the desired range, facilitating
therapy adjustment that may minimise these excursions. Contradictions Successful operation of
CGM requires adequate vision and hearing. Use of CGM is not recommended for patients whose
impaired vision or hearing does not allow full recognition of the monitors signals and alarms, or who
do not have a caregiver who can perform this function for them.
© 2011 Medtronic Australasia Pty Ltd. All rights reserved. CGMPRAC 211111
Paradigm, Veo, Guardian, MiniLink, Bolus Wizard and Enlite are trademarks and
Medtronic CareLink is registered trademark of Medtronic MiniMed, Inc.
IV3000 is a registered trademark of TJ Smith & Nephew Ltd.
Adobe and Acrobat are registered trademark of Adobe Systems Inc.
www.medtronic-diabetes.com.au
Medtronic Diabetes 24-Hour HelpLine
T: 1800 777 808
MedtronicAustralasiaPtyLtd•Diabetes
97 Waterloo Road, North Ryde NSW 2113 Australia
T:0298579000•F:0298871829
www.medtronic.com.au